home / stock / bcda / bcda short
Short Information | BioCardia Inc. (OTCMKTS:BCDA)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 27,740 |
Total Actual Volume | 73,340 |
Short Trends | |
---|---|
Cover Days | 6 |
Short Days | 7 |
No Change Days | 7 |
Averages | |
---|---|
Average Short Volume | 1,387 |
Average Short Percentage | 44.24% |
Is there a BCDA Short Squeeze or Breakout about to happen?
See the BCDA Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
08-01-2019 | $16.25 | $14.00 | $16.25 | $14.00 | 6,538 | 3,259 | 49.85% |
07-31-2019 | $13.50 | $17.00 | $17.50 | $13.50 | 6,097 | 2,327 | 38.17% |
07-30-2019 | $10.51 | $12.00 | $14.19 | $10.51 | 5,121 | 3,053 | 59.62% |
07-29-2019 | $8.63 | $10.55 | $14.70 | $8.50 | 4,223 | 1,934 | 45.8% |
07-26-2019 | $8.40 | $8.63 | $8.63 | $8.40 | 4,338 | 1,757 | 40.5% |
07-25-2019 | $7.90 | $8.38 | $8.45 | $7.30 | 2,071 | 1,475 | 71.22% |
07-24-2019 | $7.30 | $7.30 | $7.30 | $7.30 | 202 | 202 | 100% |
07-23-2019 | $8.55 | $8.55 | $8.55 | $8.55 | 180 | 100 | 55.56% |
07-19-2019 | $8.50 | $8.63 | $8.63 | $8.50 | 1,157 | 158 | 13.66% |
07-18-2019 | $8.22 | $8.25 | $8.25 | $8.00 | 1,800 | 89 | 4.94% |
07-17-2019 | $8.375 | $8.16 | $8.375 | $8.16 | 913 | 450 | 49.29% |
07-12-2019 | $N/A | $10.00 | $N/A | $N/A | 151 | 50 | 33.11% |
06-05-2019 | $1.20 | $1.24 | $1.2405 | $1.20 | 4,250 | 2,951 | 69.44% |
05-30-2019 | $1.02 | $1.00 | $1.02 | $1.00 | 3,669 | 1,466 | 39.96% |
05-24-2019 | $1.10 | $1.00 | $1.12 | $1.00 | 7,650 | 5,775 | 75.49% |
05-23-2019 | $1.09 | $1.05 | $1.25 | $1.05 | 14,845 | 560 | 3.77% |
05-21-2019 | $1.25 | $1.25 | $1.25 | $1.25 | 1,098 | 750 | 68.31% |
05-20-2019 | $1.19 | $1.26 | $1.30 | $1.19 | 1,060 | 100 | 9.43% |
05-16-2019 | $1.00 | $1.17 | $1.17 | $0.95 | 7,773 | 1,200 | 15.44% |
05-14-2019 | $1.05 | $1.05 | $1.05 | $1.05 | 204 | 84 | 41.18% |
News, Short Squeeze, Breakout and More Instantly...
SUNNYVALE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the primary endpoint results of the open label roll-in cohort of the CardiAMP&...
SUNNYVALE, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced completion of enrollment and collection of the primary endpoint results of t...
The Dow Jones index closed higher by over 200 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern aro...